Search Results
Results found for "Norton Cheng"
- GPCR Collaboration: From Models to Medicine
That perspective changed the moment he entered GPCR research . That candor changes the tone of collaboration . Pharmacologists know they aren’t being oversold. It also allows Carlsson to stay plugged into the fast-changing needs of biotech while keeping his academic
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Hauser Calcineurin-fusion facilitates cryo-EM structure determination of a Family A GPCR Jun Xu , Geng Chen , Haoqing Wang , Sheng Cao , Jie Heng , Xavier Deupi , Yang Du , Brian K Kobilka Red and far-red cleavable Ramona Birke , Joshua Levitz , Ben Jones , Johannes Broichhagen Design of allosteric modulators that change This change is all about keeping our community strong and delivering top-notch content. the discovery of antibodies, which recognized native receptor Design of allosteric modulators that change
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
is like adjusting the brightness on a microscope—set it right, and hidden details jump into focus, changing Can changing receptor density predict how your drug will behave across sensitive versus less sensitive That’s where Terry’s Corner changes the game.
- 📰 GPCR Weekly News, April 29 to May 5, 2024
announcements in today’s episode, so join us in this celebration and be the first to know about all the changes
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
“The first time I wore my lucky cactus shirt to a major meeting... and it led to a game-changing collaboration
- From Pipettes to Platforms: The Evolution of GPCR Research
What Changed After This : High-throughput capabilities meant researchers could map GPCR signaling more But the heart of the field hasn’t changed.
- G protein coupling and activation of the metabotropic GABAB heterodimer
Cryo-electron microscopy studies revealed a drastic conformational change upon activation and a unique metadynamics computations to predict the mechanism by which the inactive GP induces conformational changes
- β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...
Moreover, we assess β-arrestin conformational changes that are induced specifically by proximal and distal Here, we show differences between conformational changes that are induced by P-R* or R* receptor states
- GPCR Biased Signaling and Molecular Glues
This AMA examines how these formats diverge, particularly for allosteric ligands, where efficacy can change Allosteric modulators can alter signaling efficacy without changing ligand affinity, uncoupling binding
- Why “Displacement” Misleads You: Allosteric Binding Demystified
Session, You’ll Gain: ✅ A clear explanation of why allosteric modulators don’t displace ligands—they change You’re no longer tracking the same protein species—and that changes everything.
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
The date never changed. But the scope moved. If nothing changes after it, it was just a lab update. shared, milestone-driven roadmap tied to strategic decisions, not just scientific deliverables, momentum changes
- The Hidden Operating Cadence That’s Actually Driving Your Biotech
And until you see it, you can’t change it. What must change? What deserves escalation? ✅ A stable cadence doesn’t eliminate surprise.
- How System-Level GPCR Thinking Prevents Discovery Failures
Johannes Broichhagen Reliable imaging tools change how researchers see receptor behavior. specificity, relevance, and assay confidence Read the full HCS feature ➤ Why System-Level GPCR Thinking Changes
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
al. highlight the importance of GPCR dimers in drug discovery referring to important conformational changes But what are the conformation changes that drive GPCR dimerization? The interaction between two receptors in a dimer involves a conformational change in the transmembrane Interestingly, the amplitude of the conformational changes due to ligand binding is limited at these
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
This week brings sharp new insights into how minor changes in ligand structure can flip GPCR function
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
characterization of biased receptors may give insights into the relationship between the conformational change protein coupling bias of mutant AVPR2s may broaden our understanding of the relationship between the changed
- SLAS2022 International Conference and Exhibition
We are closely monitoring any regulation changes from both Boston and Massachusetts with regard to in-person If there are any changes made that will impact our ability to hold the event in-person, we will notify
- How Early Strategic Decision Making Creates Alignment and Better Results
They only feel the consequences months later, when it is hard to change momentum. 👉 This article is Why Results Appear Too Late to Change the Outcome 👉 Most teams focus on results because results feel underlying strategy is sound. 👉 When early strategic decision-making creates alignment, something changes
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of µ-opioid receptors
severe pain by activating the μ-opioid receptor (MOR), whereas naloxone, with only slight structural changes The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
Additionally, pull-down experiments demonstrated that YM promotes similar conformational changes in both Together, these results indicate that changes in membrane binding impact the ability of YM to inhibit
- Synaptic integration of subquantal neurotransmission by co-localized G protein coupled receptors in
We tested effects of changes in vesicle numbers undergoing fusion at single synapses, relative placement Experimental effects of Pr changes, consistent with GABAB receptor effects, were straightforwardly represented by changes in numbers of synapses. GABAB receptors alter Pr leaving synaptic properties unchanged, while 5-HT1B receptors fundamentally change
- 📰 GPCR Weekly News, March 20 to 26, 2023
Structural and Molecular Insights into GPCR Function Physiological changes in bilayer thickness induced Ultrafast structural changes direct the first molecular events of vision. Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
But everything changed when his recurring pain — and the rigid protocols around opioid prescription —
- The NPXXY Motif Regulates β-Arrestin Recruitment by the CB1 Cannabinoid Receptor
transmembrane helix 7 (TMH7) and the highly conserved NPXXY motif can be subject to different conformational changes
- ShouTi Pharma has a brand new website
experienced, innovative, global team on a bold mission to improve health by creating and developing life-changing
- β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
-ADR agonist terbutaline by flow cytometry. β2-ADR-expressing B cells increase during CIA without a change The change of β2-ADR expression and signaling during sustained inflammation might be an integral part
- First AMA of 2026: GPCR Pharmacology, Biased Signaling & Mechanistic Clarity
definitive during early screening can shift as assay systems, receptor expression levels, or kinetics change
- Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and...
August 2022 Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
the Danger Perhaps the most unsettling part of Catherine’s work is the disconnect between breathing changes That is why Catherine’s work matters: it shows in mechanistic detail how fentanyl and xylazine change
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
Kenakin reveals how scaled pharmacological metrics allow teams to interpret receptor signaling changes Drug concentrations constantly change as molecules: distribute through tissues bind and unbind receptors
















